Patents by Inventor Christopher G. Winter

Christopher G. Winter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PLKS as modifiers of the beta catenin pathway and methods of use
    Patent number: 8632962
    Abstract: Human PLK genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of PLK are provided.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: January 21, 2014
    Assignee: Exelixis, Inc.
    Inventors: Helen Francis-Lang, Christopher G. Winter, Richard Benn Abegania Ventura, Lynn Margaret Bjerke, Timothy S. Heuer
  • VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use
    Publication number: 20100112566
    Abstract: Human VIPR1 genes are identified as modulators of the E2F/RB pathway, and thus are therapeutic targets for disorders associated with defective E2F/RB function. Methods for identifying modulators of E2F/RB, comprising screening for agents that modulate the activity of VIPR1 are provided.
    Type: Application
    Filed: September 24, 2007
    Publication date: May 6, 2010
    Inventors: Kyle A. Edgar, Kimberly Carr Ferguson, Monique Nicoll, Christopher G. Winter
  • Plks as Modifiers of the Beta Catenin Pathway and Methods of Use
    Publication number: 20080274122
    Abstract: Human PLK genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of PLK are provided.
    Type: Application
    Filed: November 23, 2004
    Publication date: November 6, 2008
    Applicant: EXELIXIS, INC.
    Inventors: Helen Francis-Lang, Christopher G. Winter, Richard Benn Abegania Ventura, Lynn Margaret Bjerke, Timothy S. Heuer
  • Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of Use
    Publication number: 20080050313
    Abstract: Human SULF genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of SULF are provided.
    Type: Application
    Filed: August 12, 2004
    Publication date: February 28, 2008
    Applicant: Exelixis, Inc.
    Inventors: Helen Francis-Lang, Christopher G. Winter, Richard Benn Abegania Ventura, HaiGuang Zhang, Timothy S. Heuer